Upon conclusion of this program, participants should be able to:

• Describe the current status of stroke prevention options in atrial fibrillation
• Identify which patients are at risk for sudden death and how to best treat them
• Demonstrate appropriate use of medications and cardiac resynchronization therapy for heart failure
• Review the role of new treatments for heart failure including LVADs and transplantation
• Recognize the latest diagnostic and management strategies for hypertrophic cardiomyopathy
• Assess the current status of interventions for structural heart disease
• Describe cardiovascular risk factors, current guidelines, and new strategies for prevention

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.